NO2231189T3 - - Google Patents

Info

Publication number
NO2231189T3
NO2231189T3 NO08861526A NO08861526A NO2231189T3 NO 2231189 T3 NO2231189 T3 NO 2231189T3 NO 08861526 A NO08861526 A NO 08861526A NO 08861526 A NO08861526 A NO 08861526A NO 2231189 T3 NO2231189 T3 NO 2231189T3
Authority
NO
Norway
Application number
NO08861526A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40795732&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2231189(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NO2231189T3 publication Critical patent/NO2231189T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO08861526A 2007-12-19 2008-12-18 NO2231189T3 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/SE2007/001127 WO2009078754A1 (en) 2007-12-19 2007-12-19 Drug delivery system for administration of poorly water soluble pharmaceutically active substances
PCT/SE2008/051515 WO2009078802A1 (en) 2007-12-19 2008-12-18 Drug delivery system for administration of poorly water soluble pharmaceutically active substances

Publications (1)

Publication Number Publication Date
NO2231189T3 true NO2231189T3 (enExample) 2018-02-03

Family

ID=40795732

Family Applications (2)

Application Number Title Priority Date Filing Date
NO08861526A NO2231189T3 (enExample) 2007-12-19 2008-12-18
NO2019023C NO2019023I1 (no) 2007-12-19 2019-05-08 Paclitaxel micellar

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2019023C NO2019023I1 (no) 2007-12-19 2019-05-08 Paclitaxel micellar

Country Status (27)

Country Link
US (4) US8999382B2 (enExample)
EP (1) EP2231189B1 (enExample)
JP (1) JP5466172B2 (enExample)
KR (1) KR101572703B1 (enExample)
CN (1) CN101951956B (enExample)
AU (1) AU2008339099B2 (enExample)
BR (1) BRPI0821740B1 (enExample)
CA (1) CA2709266C (enExample)
CY (2) CY1119805T1 (enExample)
DK (1) DK2231189T3 (enExample)
EA (1) EA015247B1 (enExample)
ES (1) ES2650242T3 (enExample)
FR (1) FR19C1030I1 (enExample)
HR (1) HRP20171796T1 (enExample)
HU (1) HUE034684T2 (enExample)
LT (2) LT2231189T (enExample)
LU (1) LUC00117I2 (enExample)
MX (1) MX2010006914A (enExample)
MY (2) MY157187A (enExample)
NL (1) NL300987I9 (enExample)
NO (2) NO2231189T3 (enExample)
NZ (1) NZ586859A (enExample)
PL (1) PL2231189T3 (enExample)
PT (1) PT2231189T (enExample)
SI (1) SI2231189T1 (enExample)
WO (2) WO2009078754A1 (enExample)
ZA (1) ZA201004685B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009078755A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078756A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078754A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of poorly water soluble pharmaceutically active substances
AU2010239689A1 (en) * 2009-04-21 2011-11-03 Selecta Biosciences, Inc. Immunonanotherapeutics providing a Th1-biased response
CA2798323A1 (en) 2010-05-26 2011-12-01 Selecta Biosciences, Inc. Dose selection of adjuvanted synthetic nanocarriers
EP2640190A4 (en) 2010-11-05 2016-05-11 Selecta Biosciences Inc MODIFIED NICOTINIC COMPOUNDS AND ASSOCIATED METHODS
CN103908432B (zh) * 2013-01-02 2018-09-21 博瑞生物医药（苏州）股份有限公司 一种伊沙匹隆白蛋白的冻干组合物及其制备方法
CN112239418B (zh) * 2019-07-18 2023-07-07 上海现代药物制剂工程研究中心有限公司 视黄醇类化合物及其钠盐的制备方法
CN112321465B (zh) 2019-07-18 2023-06-06 上海现代药物制剂工程研究中心有限公司 一种含苯基化合物、其中间体、制备方法及应用
WO2021259472A1 (en) * 2020-06-24 2021-12-30 Oasmia Pharmaceutical Ab Micellar docetaxel for use in the treatment of cancer
CN115429886B (zh) * 2021-06-02 2025-10-31 复旦大学 一种药物纳米结晶制剂及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096331A (en) * 1993-02-22 2000-08-01 Vivorx Pharmaceuticals, Inc. Methods and compositions useful for administration of chemotherapeutic agents
DE19839566C2 (de) * 1998-08-31 2002-01-17 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten in der Transplantationsmedizin
US6197809B1 (en) * 1998-12-23 2001-03-06 Ardenia Investments Ltd. Compounds for the treatment of cancer
US6656504B1 (en) * 1999-09-09 2003-12-02 Elan Pharma International Ltd. Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
SE0101702D0 (sv) * 2001-05-15 2001-05-15 Ardenia Investments Ltd Novel potentiating compounds
US20050191359A1 (en) * 2001-09-28 2005-09-01 Solubest Ltd. Water soluble nanoparticles and method for their production
US20050249786A1 (en) * 2001-09-28 2005-11-10 Solubest Ltd. Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
CN100360502C (zh) * 2002-07-23 2008-01-09 阿登尼亚投资有限公司 视黄醇衍生物、它们在治疗癌症和增强其它细胞毒性剂功效中的应用
SE0202311D0 (sv) * 2002-07-23 2002-07-23 Ardenia Investments Ltd Novel compounds, cytotoxic preparations comprising said compounds, methods of manufacture of said preparations, as well as methods of treatment
US7259984B2 (en) * 2002-11-26 2007-08-21 Cornell Research Foundation, Inc. Multibit metal nanocrystal memories and fabrication
JP2006199590A (ja) 2003-09-04 2006-08-03 Nano Career Kk 水溶性の塩基性薬物内包ナノ粒子含有組成物
WO2005089106A2 (en) 2004-02-27 2005-09-29 Molecular Therapeutics, Inc. Degradable nanoparticles
US7871632B2 (en) 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
WO2007001356A2 (en) * 2004-09-10 2007-01-04 University Of Wyoming Nanoparticles for cytoplasmic drug delivery to cancer cells
CA2620389C (en) * 2005-08-31 2014-06-17 Abraxis Bioscience, Llc Compositions and methods for preparation of poorly water soluble drugs with increased stability
WO2009078756A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078755A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078754A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of poorly water soluble pharmaceutically active substances

Also Published As

Publication number Publication date
PT2231189T (pt) 2017-12-12
LT2231189T (lt) 2017-12-27
AU2008339099B2 (en) 2015-08-13
MX2010006914A (es) 2010-11-10
CY2019021I2 (el) 2019-11-27
NZ586859A (en) 2012-06-29
EA015247B1 (ru) 2011-06-30
USRE49741E1 (en) 2023-12-05
LUC00117I2 (enExample) 2024-05-22
WO2009078754A1 (en) 2009-06-25
EP2231189A4 (en) 2013-10-09
US20150164819A1 (en) 2015-06-18
CY2019021I1 (el) 2019-11-27
CY1119805T1 (el) 2018-06-27
ZA201004685B (en) 2011-03-30
NL300987I9 (nl) 2019-05-16
DK2231189T3 (en) 2017-12-11
LTPA2019508I1 (lt) 2019-05-10
CA2709266A1 (en) 2009-06-25
HRP20171796T1 (hr) 2018-01-26
MY157186A (en) 2016-05-13
BRPI0821740A2 (pt) 2020-02-27
EA200802350A3 (ru) 2009-10-30
US8999382B2 (en) 2015-04-07
MY157187A (en) 2016-05-13
EP2231189B1 (en) 2017-09-06
KR20100094575A (ko) 2010-08-26
NO2019023I1 (no) 2019-05-08
SI2231189T1 (en) 2018-03-30
CA2709266C (en) 2017-09-26
CN101951956A (zh) 2011-01-19
USRE49742E1 (en) 2023-12-05
JP5466172B2 (ja) 2014-04-09
EA200802350A2 (ru) 2009-06-30
US9993438B2 (en) 2018-06-12
WO2009078802A1 (en) 2009-06-25
HUE034684T2 (en) 2018-02-28
BRPI0821740B1 (pt) 2021-05-18
JP2011507838A (ja) 2011-03-10
FR19C1030I1 (fr) 2019-06-21
ES2650242T3 (es) 2018-01-17
EP2231189A1 (en) 2010-09-29
PL2231189T3 (pl) 2018-03-30
AU2008339099A1 (en) 2009-06-25
CN101951956B (zh) 2012-10-17
KR101572703B1 (ko) 2015-11-27
NL300987I2 (enExample) 2019-05-09
US20110014281A1 (en) 2011-01-20

Similar Documents

Publication Publication Date Title
NL300987I2 (enExample)
CN300729290S (zh) 铰链(c)
CN300729515S (zh) 山茶油包装盒
CN300911212S (zh) 带炉灶的洗物台
CN300888467S (zh) 茶几
CN300885731S (zh) 面料(2)
CN300878193S (zh) 拖鞋(19)
CN300871978S (zh) 衬衫(2007011)
CN300868118S (zh) 包装封口
CN300835234S (zh) 太阳能围栏立柱灯(3)
CN300833251S (zh) 布料(68)
CN300832424S (zh) 冰箱(双门2007-1)
CN300831557S (zh) 镶嵌玻璃(63)
CN300830130S (zh) 工艺品(唱诗班-母亲)
CN300821895S (zh) 电视机机壳(pdp3202)
CN300797591S (zh) 包装盒
CN300791266S (zh) 充气玩具(175)
CN300774056S (zh) 面料(07-08)
CN300763256S (zh) 地毯(27-131)
CN300761560S (zh) 激光投线仪(lp40)
CN300755028S (zh) 象棋纸
CN300729522S (zh) 包装盒（金典均衡双蛋白奶）
CN300729516S (zh) 药品包装盒
CN300729482S (zh) 包装盒(思乐奇)
CN300729228S (zh) 美工刀刀片